Cell-extracellular matrix interactions and EGF are important regulators of the basal mammary epithelial cell phenotype.
The mammary epithelium is composed of a luminal epithelium and a basal layer containing myoepithelial cells and undifferentiated precursors. Basal cells express specific protein markers, such as keratin 14 (K14) and P-cadherin. To study the factors that regulate the basal mammary epithelial cell phenotype, we have established two clonal derivatives of the mouse HC11 cell line, BC20 and BC44, expressing high levels of K14 and P-cadherin. Unlike the parental HC11 cells, these basal cells did not produce beta-casein in response to lactogenic hormone treatment; however their phenotype appeared to be plastic. Cultured in EGF-free medium, they exhibited enhanced cell-extracellular matrix adhesions and deficient cell-cell junctions, whereas long-term treatment with EGF induced a decrease of focal contact number and establishment of cell-cell junctions, resulting in downregulation of K14 and P-cadherin expression at the protein and mRNA levels. To determine whether cell-extracellular matrix interactions mediated by integrins have a role in the regulation of the expression of K14 and P-cadherin, the amounts of transcripts for the two proteins were analysed in the basal cells, which were plated on the function-blocking antibodies against beta1 and alpha6 integrin chains, on fibronectin and on laminin 5. The amount of P-cadherin transcript was 2- to 4-fold higher in cells plated on the function-blocking anti-integrin antibodies and on the extracellular matrix proteins, as compared to cells plated on poly-L-lysine, whereas the K14 transcript levels were not significantly modified in response to adhesion. The data demonstrate that integrin-mediated cell interaction with extracellular matrix is directly implicated in the control of P-cadherin expression, and that EGF and cell-extracellular matrix adhesion events are important regulators of the basal mammary epithelial cell phenotype.
Deugnier
M A
MA
UMR144, CNRS-Institut Curie, Section de Recherche, 75248-Paris Cedex 05, France.
Faraldo
M M
MM
Rousselle
P
P
Thiery
J P
JP
Glukhova
M A
MA
D000818:Animals; D015152:Blotting, Northern; D015820:Cadherins / Q000378:metabolism; D002364:Caseins / Q000378:metabolism; D002448:Cell Adhesion; D002460:Cell Line; D003598:Cytoskeletal Proteins / Q000378:metabolism; D051180:Desmoplakins; D003907:Dexamethasone / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000502:physiology*; D004847:Epithelial Cells / Q000378:metabolism*; D005109:Extracellular Matrix / Q000502:physiology*; D005434:Flow Cytometry; D015151:Immunoblotting; D007328:Insulin / Q000494:pharmacology; D016023:Integrins / Q000502:physiology; D053547:Keratin-14; D007633:Keratins / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000378:metabolism*; D051379:Mice; D008856:Microscopy, Fluorescence; D010641:Phenotype; D011388:Prolactin / Q000494:pharmacology; D015534:Trans-Activators; D015854:Up-Regulation; D051178:alpha Catenin; D051176:beta Catenin
C495267:CTNNB1 protein, mouse; D015820:Cadherins; D002364:Caseins; C495272:Ctnna1 protein, mouse; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D007328:Insulin; D016023:Integrins; D053547:Keratin-14; C507446:Krt14 protein, mouse; D015534:Trans-Activators; D051178:alpha Catenin; D051176:beta Catenin; D004815:Epidermal Growth Factor; D007633:Keratins; D003907:Dexamethasone; D011388:Prolactin